Albemarle — Apr 30, 2025 release

Other Corporate FY 2025E Capital expenditures $700 - $800 million Depreciation and amortization $630 - $670 million Adjusted effective tax rate (a) (40%) - 25% Corporate costs (b) $70 - $100 million Interest and financing expenses $180 - $210 million Weighted-average common shares outstanding (diluted) 118 million (a)    Adjusted effective tax rate dependent on lithium market prices and geographic income mix (b)    FY 2025E outlook includes FX impact year to date Cash Flow and Capital Deployment Cash from operations of $545 million increased $447 million compared to the prior-year period. A customer prepayment received in January and improved working capital more than offset lower adjusted EBITDA and reduced dividends received from equity investments. Capital expenditures of $183 million decreased by $397 million versus the prior-year period, reflecting the impact of decisions that stopped or slowed spending and the completion of capacity expansions in Energy Storage and Specialties. Balance Sheet and Liquidity As of March 31, 2025, Albemarle had estimated liquidity of approximately $3.1 billion, including $1.5 billion of cash and cash equivalents, $1.5 billion available under its revolver and $106 million available under other credit lines. Total debt was $3.5 billion, representing a debt covenant net debt to adjusted EBITDA ratio of approximately 2.4 times. 3 Earnings Call Date: Thurs., May 1, 2025 Time: 8:00 AM Eastern time